Literature DB >> 15036536

Resistance of broiler chickens to Escherichia coli respiratory tract infection induced by passively transferred egg-yolk antibodies.

S Kariyawasam1, B N Wilkie, C L Gyles.   

Abstract

Egg-yolk antibodies induced by immunizing hens with selected Escherichia coli antigens were evaluated for their ability to protect broiler chickens against respiratory/septicemic disease caused by avian pathogenic E. coli (APEC). Seven groups of broiler breeder hens were vaccinated three times, 1 week apart with live E. coli, killed E. coli, E. coli antigens [lipopolysaccharide (LPS), type 1 pilus adhesin (FimH), P pilus adhesin (PapG), aerobactin outer membrane receptor (IutA)] or phosphate buffered saline (PBS). An O78 APEC strain was used for preparation of all the antigens. Egg yolk immunoglobulins (IgY) were purified from eggs of each group and antibody activity in serum and purified IgY was determined by enzyme-linked immunosorbent assay (ELISA). IgY (100mg) was injected intramuscularly into 11-day-old broiler chickens, which were challenged 3 days later with homologous (O78) or heterologous (O1 or O2) E. coli by the intra-air sac route. Mortality was recorded and surviving chickens were euthanized 1 week after the challenge and examined for macroscopic lesions. Passive antibodies against all antigens except FimH were protective (90-100%) against the homologous challenge, but only anti-PapG and anti-IutA were effective against heterologous challenge. Anti-PapG IgY provided the greatest protection against the three serogroups of E. coli used for challenge. Hence vaccination of broiler breeders to induce anti-PapG and anti-IutA antibodies may provide passive protection of progeny chicks against respiratory/septicemic disease caused by APEC.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15036536     DOI: 10.1016/j.vetmic.2003.10.022

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  16 in total

1.  Puzzling inefficiency of H5N1 influenza vaccines in Egyptian poultry.

Authors:  Jeong-Ki Kim; Ghazi Kayali; David Walker; Heather L Forrest; Ali H Ellebedy; Yolanda S Griffin; Adam Rubrum; Mahmoud M Bahgat; M A Kutkat; M A A Ali; Jerry R Aldridge; Nicholas J Negovetich; Scott Krauss; Richard J Webby; Robert G Webster
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-01       Impact factor: 11.205

2.  FimH can directly activate human and murine natural killer cells via TLR4.

Authors:  M Firoz Mian; Nicole M Lauzon; David W Andrews; Brian D Lichty; Ali A Ashkar
Journal:  Mol Ther       Date:  2010-05-04       Impact factor: 11.454

3.  Protection of Carassius auratus Gibelio against infection by Aeromonas hydrophila using specific immunoglobulins from hen egg yolk.

Authors:  Xiao-liang Li; Jiang-bing Shuai; Wei-huan Fang
Journal:  J Zhejiang Univ Sci B       Date:  2006-11       Impact factor: 3.066

4.  Immune responses to oral vaccination with Salmonella-delivered avian pathogenic Escherichia coli antigens and protective efficacy against colibacillosis.

Authors:  John Hwa Lee; Atul A Chaudhari; In Gyoung Oh; Seong Kug Eo; Sang-Youel Park; Chetan V Jawale
Journal:  Can J Vet Res       Date:  2015-07       Impact factor: 1.310

5.  Sequence analysis and characterization of a transferable hybrid plasmid encoding multidrug resistance and enabling zoonotic potential for extraintestinal Escherichia coli.

Authors:  Timothy J Johnson; Dianna Jordan; Subhashinie Kariyawasam; Adam L Stell; Nathan P Bell; Yvonne M Wannemuehler; Claudia Fernández Alarcón; Ganwu Li; Kelly A Tivendale; Catherine M Logue; Lisa K Nolan
Journal:  Infect Immun       Date:  2010-02-16       Impact factor: 3.441

6.  In vitro inhibition of oral Candida albicans by chicken egg yolk antibody (IgY).

Authors:  X Z Wang; B Fan; L G Liu; X Y Hu; R Y Li; Y Wei; Z Wan; X L Deng
Journal:  Mycopathologia       Date:  2008-03-14       Impact factor: 2.574

7.  In vitro reactivity and growth inhibition of EPEC serotype O111 and STEC serotypes O111 and O157 by homologous and heterologous chicken egg yolk antibody.

Authors:  José Araujo Amaral; Milene Tino De Franco; Lucy Zapata-Quintanilla; Solange Barros Carbonare
Journal:  Vet Res Commun       Date:  2007-12-11       Impact factor: 2.459

8.  Immune responses associated with homologous protection conferred by commercial vaccines for control of avian pathogenic Escherichia coli in turkeys.

Authors:  Jean-Rémy Sadeyen; Zhiguang Wu; Holly Davies; Pauline M van Diemen; Anita Milicic; Roberto M La Ragione; Pete Kaiser; Mark P Stevens; Francis Dziva
Journal:  Vet Res       Date:  2015-01-23       Impact factor: 3.683

9.  FimH adhesin of type 1 fimbriae is a potent inducer of innate antimicrobial responses which requires TLR4 and type 1 interferon signalling.

Authors:  Ali A Ashkar; Karen L Mossman; Brian K Coombes; Carlton L Gyles; Randy Mackenzie
Journal:  PLoS Pathog       Date:  2008-12-05       Impact factor: 6.823

Review 10.  Immunoglobulin Y for Potential Diagnostic and Therapeutic Applications in Infectious Diseases.

Authors:  Lucia Lee; Kate Samardzic; Michael Wallach; Lyn R Frumkin; Daria Mochly-Rosen
Journal:  Front Immunol       Date:  2021-06-09       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.